U.S., April 17 -- ClinicalTrials.gov registry received information related to the study (NCT07534176) titled 'To Evaluate the Impact of Smoking on PK After Single-dose Oral Administration of GS1-144 Tablets .' on March 25.
Brief Summary: A Drug-Drug Interaction Study to Evaluate the Effect of Smoking (CYP1A2 Inducer) on the Pharmacokinetics Following a Single Oral Dose of GS1-144 Tablets in Chinese Healthy Postmenopausal Female Trial Participants
Study Start Date: May 27
Study Type: INTERVENTIONAL
Condition:
Postmenopause
Intervention:
DRUG: GS1-144 tablets
All trial participants will receive the investigational drug (GS1-144 tablets) at a dose of 30 mg.
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Changchun GeneScience Pharmac...